当前位置: X-MOL 学术Exp. Cell Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
ICBP90, an epigenetic regulator, induces DKK3 promoter methylation, promotes glioma progression, and reduces sensitivity to cis-platinum
Experimental Cell Research ( IF 3.3 ) Pub Date : 2024-02-22 , DOI: 10.1016/j.yexcr.2024.113976
Qinchen Cao 1 , Xinxin Wang 2 , Jie Liu 3 , Yang Dong 4 , Xiaolong Wu 5 , Yin Mi 1 , Ke Liu 1 , Mingzhi Zhang 5 , Yonggang Shi 1 , Ruitai Fan 1
Affiliation  

Glioma is the most common brain malignancy, characterized by high morbidity, high mortality, and treatment-resistance. Inverted CCAAT box Binding Protein of 90 kDa (ICBP90) has been reported to be involved in tumor progression and the maintenance of DNA methylation. Herein, we constructed ICBP90 over-expression and knockdown glioma cell lines, and found that ICBP90 knockdown inhibited glioma cell proliferation, migration, and invasion. ICBP90 silencing potentially enhanced cellular sensitivity to -platinum (DDP) and exacerbated DDP-induced pyroptosis, manifested by the elevated levels of gasdermin D-N-terminal and cleaved caspase 1; whereas, ICBP90 over-expression exhibited the opposite effects. Consistently, ICBP90 knockdown inhibited tumor growth in an mouse xenograft study using U251 cells stably expressing sh-ICBP90 and oe-ICBP90. Further experiments found that ICBP90 reduced the expression of Dickkopf 3 homolog (DKK3), a negative regulator of β-catenin, by binding its promoter and inducing DNA methylation. ICBP90 knockdown prevented the nuclear translocation of β‐catenin and suppressed the expression of c-Myc and cyclin D1. Besides, DKK3 over-expression restored the effects of ICBP90 over-expression on cell proliferation, migration, invasion, and DDP sensitivity. Our findings suggest that ICBP90 inhibits the expression of DKK3 in glioma by maintaining DKK3 promoter methylation, thereby conducing to ICBP90-mediated carcinogenesis and drug insensitivity.

中文翻译:


ICBP90 是一种表观遗传调节因子,可诱导 DKK3 启动子甲基化,促进神经胶质瘤进展,并降低对顺铂的敏感性



胶质瘤是最常见的脑恶性肿瘤,具有高发病率、高死亡率和治疗耐药性的特点。据报道,90 kDa 的反向 CCAAT 盒结合蛋白 (ICBP90) 参与肿瘤进展和 DNA 甲基化的维持。在此,我们构建了ICBP90过表达和敲低的胶质瘤细胞系,发现ICBP90敲低抑制了胶质瘤细胞的增殖、迁移和侵袭。 ICBP90 沉默可能增强细胞对铂 (DDP) 的敏感性,并加剧 DDP 诱导的细胞焦亡,表现为gasdermin DN 末端和 cleaved caspase 1 水平升高;而ICBP90过表达则表现出相反的效果。一致地,在使用稳定表达 sh-ICBP90 和 oe-ICBP90 的 U251 细胞的小鼠异种移植研究中,ICBP90 敲低抑制了肿瘤生长。进一步的实验发现,ICBP90 通过结合其启动子并诱导 DNA 甲基化,降低了β-连环蛋白负调节因子 Dickkopf 3 同源物 (DKK3) 的表达。 ICBP90 敲低可阻止 β-catenin 的核转位并抑制 c-Myc 和细胞周期蛋白 D1 的表达。此外,DKK3过表达恢复了ICBP90过表达对细胞增殖、迁移、侵袭和DDP敏感性的影响。我们的研究结果表明,ICBP90 通过维持 DKK3 启动子甲基化来抑制神经胶质瘤中 DKK3 的表达,从而导致 ICBP90 介导的致癌作用和药物不敏感性。
更新日期:2024-02-22
down
wechat
bug